2012

“EVENTS” 3D text surrounded by calendar dates. Part of a series.

  • Milagen is pleased to receive from the Mexico Regulatory Agency COFEPRIS the approval for the commercialization in Mexico to the public and private diagnostic sector, of the following Milagen IVD products of Class I, with validity until 2017:
  • vimentin Registration # 0261R2013SSA
  •  OSPN Registration # 0301R2012SSA
  •  CD-68 Registration # 0302R2012SSA
  •  P53 Registration # 0303R2012SSA
  •  ER-ALFA Registration # 0986R2012SSA
  •  CATHEPSIN D Registration # 0304R2012SSA
  •  CA27-29 Registration # 0305R2012SSA
  •  GP100 Registration # 0187R2012SSA
  •  MART-1 Registration #  0186R2012SSA
  •  MUC-2 Registration # 0185R2012SSA
  •  CD20 Registration # 0408R2013SSA
  •  MAGE-1 Registration # 0487R2013SSA
  •  CYFRA21.1 Registration # 0485R2013SSA
  •  AFP Registration # 0987R2013SSA
  •  CA15.3 Registration # 0988R2013SSA
  •  Pro-GPR Registration # 1769R2013SSA
  •  CA-125  Registration # 1770R2013SSA
  •  Cg-A Registration # 1771R2013SSA
  •  CK16/17/18 Registration # 1772R2013SSA
  •  CD45LCA Registration # 1773R2013SSA
  •  BCL-2 Registration #  1776R2013SSA